Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume II

• Aikaterini Patsatsi,
• Maryam Daneshpazhooh,
• Soheil Tavakolpour,
• Hamidreza Mahmoudi,
• Dedee F. Murrell

Affiliations

Aikaterini Patsatsi

Autoimmune Skin and Bullous Diseases Unit, 2nd Dermatology Department, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece

Maryam Daneshpazhooh

Department of Dermatology, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran

Soheil Tavakolpour

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States

Hamidreza Mahmoudi

Department of Dermatology, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran

Dedee F. Murrell

Department of Dermatology, St George Hospital, University of New South Wales, Sydney, NSW, Australia